Accendra Health, Inc. (NYSE:ACH) (the Company) today reported financial results for the third quarter ended September 30, 2026. Unless otherwise noted, the results herein reflect the Company’s continuing operations,
Accendra Health, Inc. (NYSE:ACH) (the "Company") today announced that it executed an amendment to its Receivables Purchase Agreement (the "Receivables Sale Program") on October 29, 2026. The amendment,
Accendra Health, Inc. (NYSE:ACH) (the Company) today announced that on October 27, 2026, it received a notice (the "Notice") from the New York Stock Exchange (the "NYSE") notifying the Company that it
Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the third quarter of 2026 on Thursday, November 5, 2026, after trading ends on the New York Stock Exchange.The Company will
Accendra Health, Inc. (NYSE:ACH) (the Company) today announced that on October 6, 2026, it received a notice (the "Notice") from the New York Stock Exchange (the "NYSE") notifying the Company that
Gardner-Smith to Succeed Ed Pesicka Following Previously Announced Retirement
Company Announces Scott Lloyd as Chief Commercial Officer
Accendra Health, Inc. (NYSE:ACH) (the "Company") today named Kenneth
Accendra Health (the "Company") is providing an update on its capital allocation plans and the timeline for the replacement of its chief executive officer.
Given recent market conditions, the Company has
Accendra Health, Inc. (NYSE:ACH) (the Company) announced today that its Board of Directors adopted a Section 382 Rights Agreement (the "Tax Asset Preservation Plan") designed to protect long-term shareholder
Reduced Total Debt By $385 Million In Second Quarter
CEO Ed Pesicka Announces Intention To Retire By The End of 2026
Accendra Health, Inc. (NYSE:ACH) (the Company) today reported financial results for the second
Accendra Health, Inc. (NYSE:ACH) (the Company) today announced that President and Chief Executive Officer Edward A. Pesicka has informed the Board of Directors of his plan to retire by the end of 2026, after more than
Accendra Health today announced key leadership appointments in Information Technology and Procurement, reinforcing our commitment to building a stronger operational foundation and positioning the company for long-term
Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the second quarter of 2026 on Monday, August 10, 2026, before trading begins on the New York Stock Exchange.
The Company
Accendra Health, Inc. (NYSE:ACH) (the "Company") today announced the expiration and final results of the previously announced offers to exchange (the "Exchange Offers") any and all of the Company’s
Accendra Health, Inc. (NYSE:ACH) (the "Company") today announced the early results of the previously announced offers to exchange (the "Exchange Offers") any and all of the Company's outstanding 4.500% Senior Notes due
Accendra Health, Inc. (NYSE:ACH) (the "Company") today announced that it has commenced an offer to exchange (the "Exchange Offers") any and all of the Company's outstanding 4.500% Senior Notes due 2029 (the "2029
